Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria (Q37366842)

20 August 2017

Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria (English)

1 reference

20 August 2017

anti-retroviral agent

0 references

0 references

1 reference

0 references

1 reference

Robert Murphy

9

0 references

Chloe L Thio

11

object named as

Chloe L Thio

1 reference

20 August 2017

10

Phyllis Kanki

1 reference

20 August 2017

John Idoko

1

1 reference

20 August 2017

Seema Meloni

2

1 reference

20 August 2017

Mohammed Muazu

3

1 reference

20 August 2017

Ladep Nimzing

4

1 reference

20 August 2017

Bitrus Badung

5

1 reference

20 August 2017

Claudia Hawkins

6

1 reference

20 August 2017

Jean-Louis Sankalé

7

1 reference

20 August 2017

Ernest Ekong

8

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Clinical Infectious Diseases

20 August 2017

1 reference

20 August 2017

49

1 reference

20 August 2017

8

1 reference

20 August 2017

1268-1273

1 reference

Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Hepatitis B virus DNA is more powerful than HBeAg in predicting peripheral T-lymphocyte subpopulations in chronic HBV-infected individuals with normal liver function tests

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Human immunodeficiency virus and hepatitis B virus co-infection among patients in Kano Nigeria.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Predicting cirrhosis risk based on the level of circulating hepatitis B viral load

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2753765

Possible mechanisms underlying peripheral lymphocyte activation in chronic liver disease and asymptomatic HBsAg carriers

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19772386

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Study of T-lymphocyte subpopulation in HBsAg-positive pregnant women

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19772386

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19772386

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1086/605675

1 reference

20 August 2017

1 reference

20 August 2017

1 reference